Clinical trial
Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)
NCT00329355 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00329355 |
|---|---|
| Title | Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) |
| Official title | A Randomized, Double-blind, Single Migraine Attack, Placebo-controlled, Parallel-group Multicenter Study to Evaluate the Efficacy and Tolerability of Trexima (Sumatriptan Succinate.Naproxen Sodium) Tablets vs Placebo When Administered During the Mild Pain Phase of Menstrual Migraine in Women With… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine, Migraine Disorders |
| Intervention type | Drug |
| Interventions | sumatriptan succinate/naproxen sodium |
| Enrollment | 351 |
| Start date | May 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | May 24, 2006 |
| Last update posted | Jan 23, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: